Antonio Cannatelli

MgrB Inactivation Is a Common Mechanism of Colistin Resistance in KPC-Producing Klebsiella pneumoniae of Clinical Origin

Antonio Cannatelli, Tommaso Giani, Marco Maria D’Andrea et al. · Antimicrobial Agents and Chemotherapy · 2014 · 387 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

<i>In Vivo</i> Emergence of Colistin Resistance in Klebsiella pneumoniae Producing KPC-Type Carbapenemases Mediated by Insertional Inactivation of the PhoQ/PhoP <i>mgrB</i> Regulator

Antonio Cannatelli, Marco Maria D’Andrea, Tommaso Giani et al. · Antimicrobial Agents and Chemotherapy · 2013 · 351 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

<i>mcr-1.2</i> , a New <i>mcr</i> Variant Carried on a Transferable Plasmid from a Colistin-Resistant KPC Carbapenemase-Producing Klebsiella pneumoniae Strain of Sequence Type 512

Vincenzo Di Pilato, Fabio Arena, Carlo Tascini et al. · Antimicrobial Agents and Chemotherapy · 2016 · 155 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

<i>In Vivo</i> Evolution to Colistin Resistance by PmrB Sensor Kinase Mutation in KPC-Producing Klebsiella pneumoniae Is Associated with Low-Dosage Colistin Treatment

Antonio Cannatelli, Vincenzo Di Pilato, Tommaso Giani et al. · Antimicrobial Agents and Chemotherapy · 2014 · 147 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Characterization of Extensively Drug-Resistant or Pandrug-Resistant Sequence Type 147 and 101 OXA-48-Producing Klebsiella pneumoniae Causing Bloodstream Infections in Patients in an Intensive Care Unit

Kalliope Avgoulea, Vincenzo Di Pilato, Olympia Zarkotou et al. · Antimicrobial Agents and Chemotherapy · 2018 · 61 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17